Teleflex Appoints Sean M. Salmon to Board of Directors
Teleflex Incorporated appointed industry veteran Sean M. Salmon to its Board of Directors, effective September 8, 2026. Salmon brings more than 30 years of medical technology and pharmaceutical leadership, including more than two decades at Medtronic in cardiovascular and diabetes roles. The company said the appointment supports board governance strength and strategic value creation.